Validation of quantitative ELISAS for measuring anti-Yersinia pestis F1 and V antibody concentrations in nonhuman primate sera.

about

Validation of quantitative ELISAS for measuring anti-Yersinia pestis F1 and V antibody concentrations in nonhuman primate sera.

Item

http://www.wikidata.org/entity/Q41421634

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Validation of quantitative ELI ...... ions in nonhuman primate sera.

@en

type

Item

label

Validation of quantitative ELI ...... ions in nonhuman primate sera.

@en

prefLabel

Validation of quantitative ELI ...... ions in nonhuman primate sera.

@en

P1476

Validation of quantitative ELI ...... ions in nonhuman primate sera.

@en

P2093

B S Powell

http://www.w3.org/2001/XMLSchema#string

C R Bolt

http://www.w3.org/2001/XMLSchema#string

C Y Lindsey

http://www.w3.org/2001/XMLSchema#string

J E Brown

http://www.w3.org/2001/XMLSchema#string

J J Adamovicz

http://www.w3.org/2001/XMLSchema#string

P2860

Potential biological weapons threats

Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.

Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.

Clinical recognition and management of patients exposed to biological warfare agents.

Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.

A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.

P304

91-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15321819.2011.603774

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22181824

http://www.w3.org/2001/XMLSchema#string

P921

Yersinia pestis